These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

153 related items for PubMed ID: 9740697

  • 1. Neoadjuvant chemotherapy with mitomycin C, etoposide, and cisplatin for adenocarcinoma of the cervix.
    Iwasaka T, Fukuda K, Hara K, Yokoyama M, Nakao Y, Uchiyama M, Sugimori H.
    Gynecol Oncol; 1998 Aug; 70(2):236-40. PubMed ID: 9740697
    [Abstract] [Full Text] [Related]

  • 2. Cervical adenocarcinoma, a novel combination chemotherapy with mitomycin C, etoposide, and cisplatin for advanced or recurrent disease.
    Umesaki N, Izumi R, Fushiki H, Hasegawa K, Kono I, Nishida M, Noguchi H, Okuda H, Sugimori H, Takizawa K, Udagawa Y, Yamamoto K, Tanaka T, Noda K.
    Gynecol Oncol; 1999 Oct; 75(1):142-4. PubMed ID: 10502441
    [Abstract] [Full Text] [Related]

  • 3. Pilot study on induction chemotherapy with cisplatin, epirubicin, etoposide and bleomycin in cervical cancer stage Ib, IIa and IIb.
    Panetta A, Angelelli B, Martoni A.
    Anticancer Res; 1999 Oct; 19(1B):765-8. PubMed ID: 10216490
    [Abstract] [Full Text] [Related]

  • 4. Neoadjuvant chemotherapy using low-dose consecutive intraarterial infusions of cisplatin combined with 5-fluorouracil for locally advanced cervical adenocarcinoma.
    Aoki Y, Sato T, Watanabe M, Sasaki M, Tsuneki I, Tanaka K.
    Gynecol Oncol; 2001 Jun; 81(3):496-9. PubMed ID: 11371145
    [Abstract] [Full Text] [Related]

  • 5. A pilot study of neoadjuvant chemotherapy with mitomycin C, etoposide, cisplatin, and epirubicin for adenocarcinoma of the cervix.
    Tabata T, Nishiura K, Yanoh K, Okugawa T, Obata H, Tanaka K, Toyoda N.
    Int J Clin Oncol; 2004 Feb; 9(1):59-63. PubMed ID: 15162828
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. [Neoadjuvant chemotherapy with paclitaxel and cisplantin or carboplatin for patients with locally advanced uterine cervical cancer].
    Zhang R, Li B, Bai P, Li HJ, Li SM, Wu LY, Li W.
    Zhonghua Zhong Liu Za Zhi; 2011 Aug; 33(8):616-20. PubMed ID: 22325224
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. [Neoadjuvant chemotherapy for advanced cervical cancer].
    Kodama J, Ikuhashi H, Hongo A, Mizutani Y, Miyagi Y, Yoshinouchi M, Kobashi Y, Okuda H, Kudo T.
    Gan To Kagaku Ryoho; 1999 Jan; 26(1):89-92. PubMed ID: 9987503
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Phase II study of neoadjuvant chemotherapy with mitomycin-c, vincristine and cisplatin (MVC) in patients with stages IB2-IIB cervical carcinoma.
    Choi CH, Kim TJ, Lee JW, Kim BG, Lee JH, Bae DS.
    Gynecol Oncol; 2007 Jan; 104(1):64-9. PubMed ID: 16904170
    [Abstract] [Full Text] [Related]

  • 14. Neoadjuvant cisplatin and etoposide followed by radical hysterectomy for stage 1B-2B cervical cancer.
    Bae JH, Lee SJ, Lee A, Park YG, Bae SN, Park JS, Namkoong SE.
    Gynecol Oncol; 2008 Dec; 111(3):444-8. PubMed ID: 18829085
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Intense neoadjuvant chemotherapy with cisplatin and epirubicin for advanced or bulky cervical and vaginal adenocarcinoma.
    Zanetta G, Lissoni A, Gabriele A, Landoni F, Colombo A, Perego P, Mangioni C.
    Gynecol Oncol; 1997 Mar; 64(3):431-5. PubMed ID: 9062145
    [Abstract] [Full Text] [Related]

  • 17. Neoadjuvant chemotherapy and conservative surgery for stage IB1 cervical cancer.
    Maneo A, Chiari S, Bonazzi C, Mangioni C.
    Gynecol Oncol; 2008 Dec; 111(3):438-43. PubMed ID: 18835493
    [Abstract] [Full Text] [Related]

  • 18. Pelvic irradiation with concurrent chemotherapy versus pelvic and para-aortic irradiation for high-risk cervical cancer: an update of radiation therapy oncology group trial (RTOG) 90-01.
    Eifel PJ, Winter K, Morris M, Levenback C, Grigsby PW, Cooper J, Rotman M, Gershenson D, Mutch DG.
    J Clin Oncol; 2004 Mar 01; 22(5):872-80. PubMed ID: 14990643
    [Abstract] [Full Text] [Related]

  • 19. A randomized study of primary bleomycin, vincristine, mitomycin and cisplatin (BOMP) chemotherapy followed by radiotherapy versus radiotherapy alone in stage IIIB and IVA squamous cell carcinoma of the cervix.
    Tabata T, Takeshima N, Nishida H, Hirai Y, Hasumi K.
    Anticancer Res; 2003 Mar 01; 23(3C):2885-90. PubMed ID: 12926129
    [Abstract] [Full Text] [Related]

  • 20. Adenosquamous carcinoma versus adenocarcinoma in early-stage cervical cancer patients undergoing radical hysterectomy: an outcomes analysis.
    dos Reis R, Frumovitz M, Milam MR, Capp E, Sun CC, Coleman RL, Ramirez PT.
    Gynecol Oncol; 2007 Dec 01; 107(3):458-63. PubMed ID: 17854872
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.